Cell-Killing Protein Offers Hope for Defeating Cancer, Diabetes
By wchung | 13 Mar, 2026
A team of Australian scientists published their findings on the workings of a protein that kills cells in Monday’s issue of the journal Nature. Their work raises hope of developing drugs that can zero in on cells that cause cancer and other immune system disorders.
The protein perforin has been revealed to be the body’s defense against rogue cells that have become cancerous or hijacked by viruses by punching holes into the cells to allow toxic enzymes to invade and destroy them. This work is deemed a major advance in the field of immunology. By uncovering the precise mechanism of perforin, researchers will be able to focus their efforts on more effective and targeted ways to defeat diseases like cancer and malaria, and even disorders like diabetes.
The findings are the fruits of 10 years of collaboration between a team headed by Professor James Whisstock, an Australian Research Council Federation fellow at Monash University, a second Australian team at the Peter McCallum Cancer Institute in Melbourne, and scientists at Birkbeck College in London of Britain.
CANBERRA
Articles
- ByteDance Got Around Block on Nvidia Blackwell Chips
- Meta Delays Avocado AI Model Debut, May License Gemini in Interim
- US Seeks to Invalidate California Higher Emissions Standards
- Which Chinese EV Giant Has the Brightest Future in the Global Market?
- Rivian Rolls Out $58k R2, Promises Cheaper Variants to Come
- Iran Maintains Normal Oil Tanker Flow Through Strait of Hormuz
- US Anti-Drone Laser System Poses Risk to Airliners Says Democrat Senator
- China Imposes Mandarin First Law Over Ethnic Minorities
- Software CEOs Counter AI Threat with Swift AI Adoption and Data Moat
- China's Teapots Enjoy Profit Surge Until Oil Supplies Run Out
